NexImmune NexImmune is a biopharmaceutical company developing immunotherapy products based on the Artificial Immune Modulation nanotechnology platform. | ![]() BenevolentAI BenevolentAI is a company that develops artificial intelligence and machine learning technologies for drug discovery and life sciences. | ||
Founding Date | Founding Date 2013 | Founding Date 2011 | Founding Date 2013 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Dallas, US HQ | Locations Gaithersburg, US HQ | Locations London, GB HQ Babraham, GB |
Employees | Employees 241100% increase | Employees 5032% decrease | Employees 180 |
Valuation ($) | Valuation ($) 37.6 m | Valuation ($) 372.4 k | Valuation ($) 1 b |
Financial | |||
Cost of goods | Cost of goods $7.4m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Net income | Net income ($17.1m) (FY, 2025) | Net income ($32.3m) (FY, 2023) | Net income (€63.3m) (FY, 2023) |
Funding | |||
Total funding raised | Total funding raised $ 4.7m | Total funding raised $ 33.8m | Total funding raised $ 305m |
NexImmune is a biopharmaceutical company developing immunotherapy products based on the Artificial Immune Modulation nanotechnology platform.
View company
BenevolentAI is a company that develops artificial intelligence and machine learning technologies for drug discovery and life sciences.
View company